Dauntless Pharmaceuticals competitorsClear all

Dauntless Pharmaceuticals's top competitors include RAPT Therapeutics, Akrevia Therapeutics, Cleave Biosciences and DNAtriX.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biopharmaceutical company focused on the development of specialty drugs.
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
Akrevia Therapeutics
Akrevia Therapeutics
Akrevia Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Cleave Biosciences
Cleave Biosciences
Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.
DNAtriX
DNAtriX
DNAtrix is a biotechnology company developing virus-driven immunotherapies for cancer.
Founding Date
Founding Date
2015
Founding Date
2015
Founding Date
2015
Founding Date
2010
Founding Date
2005
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
Burlingame, US HQ
Locations
Houston, US HQ
San Diego, US
Employees
Employees
3
Employees
64
Employees
435% increase
Employees
11
Employees
205% decrease
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
156
Twitter followers
N/A
Twitter followers
161
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
196170
Alexa Website Rank
438620
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
4.7
Employee Rating
N/A
Employee Rating
3.3
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 25m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 30m (almost 2 years ago)
Latest funding round
$ 12m (about 1 year ago)
Latest funding round
$ 15.5m (about 2 years ago)
Total funding raised
Total funding raised
$ 40m
Total funding raised
$ 176m
Total funding raised
$ 37.5m
Total funding raised
$ 129m
Total funding raised
$ 54.2m
For sources of this data, please see the company profile

View company profiles

RAPT Therapeutics
HQ
South San Francisco, US
Employees
64

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.

View company
Akrevia Therapeutics
HQ
Cambridge, US
Employees
43↑ 5% increase

Akrevia Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.

View company
Cleave Biosciences
HQ
Burlingame, US
Employees
11

Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.

View company
DNAtriX
HQ
Houston, US
Employees
20↓ 5% decrease

DNAtrix is a biotechnology company developing virus-driven immunotherapies for cancer.

View company